- Home
- ATRC vs AOD Comparison
ATRC vs AOD Comparison
Compare ATRC & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- AOD
- Stock Information
- Founded
- ATRC 2000
- AOD 2006
- Country
- ATRC United States
- AOD United Kingdom
- Employees
- ATRC N/A
- AOD N/A
- Industry
- ATRC Medical/Dental Instruments
- AOD Investment Managers
- Sector
- ATRC Health Care
- AOD Finance
- Exchange
- ATRC Nasdaq
- AOD Nasdaq
- Market Cap
- ATRC 1.1B
- AOD 934.1M
- IPO Year
- ATRC 2005
- AOD N/A
- Fundamental
- Price
- ATRC $34.52
- AOD $8.66
- Analyst Decision
- ATRC Strong Buy
- AOD
- Analyst Count
- ATRC 10
- AOD 0
- Target Price
- ATRC $50.40
- AOD N/A
- AVG Volume (30 Days)
- ATRC 588.5K
- AOD 428.3K
- Earning Date
- ATRC 04-30-2025
- AOD 01-01-0001
- Dividend Yield
- ATRC N/A
- AOD 11.39%
- EPS Growth
- ATRC N/A
- AOD 213.63
- EPS
- ATRC N/A
- AOD 1.93
- Revenue
- ATRC $465,307,000.00
- AOD $72,962,082.00
- Revenue This Year
- ATRC $14.60
- AOD N/A
- Revenue Next Year
- ATRC $12.66
- AOD N/A
- P/E Ratio
- ATRC N/A
- AOD $4.49
- Revenue Growth
- ATRC 16.55
- AOD N/A
- 52 Week Low
- ATRC $18.94
- AOD $7.73
- 52 Week High
- ATRC $43.11
- AOD $9.14
- Technical
- Relative Strength Index (RSI)
- ATRC 33.27
- AOD 49.12
- Support Level
- ATRC $36.68
- AOD $8.55
- Resistance Level
- ATRC $39.71
- AOD $8.71
- Average True Range (ATR)
- ATRC 1.75
- AOD 0.11
- MACD
- ATRC -0.63
- AOD -0.01
- Stochastic Oscillator
- ATRC 9.94
- AOD 38.75
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.